 ATLANTA, Dec. 23, 2021 GLOBE NEWSWIRE -- Femasys Inc. NASDAQ: FEMY, a biomedical company aiming to meet womens needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Company is participating in the LifeSci Partners 11th Annual Corporate Access Event, which will be held virtually from January 5-7, 2022, and the H.C. Wainwright BioConnect Conference, which will be held virtually from January 10-13, 2022. 